Hemophilia A
MONDO:0010602The most common form of hemophilia characterized by spontaneous or prolonged hemorrhages due to factor VIII deficiency.
Also known as: congenital factor VIII disorder, factor VIII deficiency, haemophilia a, X-linked recessive, haemophilia type A, haemophilia type a, hemophilia A, hemophilia a, X-linked recessive, hemophilia type A
203 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Hemophilia drug study falls short: only 3 patients enrolled before termination
Disease control TerminatedThis study aimed to see if a new medicine (efanesoctocog alfa) helps people with moderate or severe hemophilia A reach their personal goals and be more physically active. It planned to enroll 35 people aged 12 to 50, but was stopped early after only 3 joined. The medicine is used…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can extra care after transplant help older patients live better?
Disease control TerminatedThis study tested two extra care programs—supportive palliative care and clinical management of other health issues—for older or frail patients who had a donor stem cell transplant. The goal was to see if these programs could improve quality of life and survival compared to stand…
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could home blood tests transform hemophilia care? study seeks patient views
Knowledge-focused TerminatedThis study looked at how patients with hemophilia A or those on blood thinners feel about monitoring their blood clotting at home. Researchers interviewed 19 people to understand their needs and hopes for a new device that could measure clotting factors. The goal was to gather in…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC